Curcumin induces apoptosis by inhibiting sarco/endoplasmic reticulum Ca2+ ATPase activity in ovarian cancer cells

Cancer Letters

Volumn 371, Issue 1, 2016, Pages 30-37

  Seo, Jeong ah ^a,b   Kim, Boyun ^b,c   Dhanasekaran, Danny N ^d   Tsang, Benjamin K ^e,f   Song, Yong Sang ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e UNIVERSITY OF OTTAWA   (Canada)

^f OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Apoptosis; Curcumin; Normal ovarian surface epithelial cell; Ovarian cancer; Sarco endoplasmic reticulum Ca2+ ATPase (SERCA)

Indexed keywords

CURCUMIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; ANTINEOPLASTIC AGENT; ATP2A2 PROTEIN, HUMAN; CALCIUM; CALCIUM CHELATING AGENT; ENZYME INHIBITOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARIAN CANCER CELL LINE; OVARY CANCER; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM; SERCA GENE; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HOMEOSTASIS; METABOLISM; OVARIAN NEOPLASMS; PATHOLOGY; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CALCIUM; CALCIUM CHELATING AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; HOMEOSTASIS; HUMANS; OVARIAN NEOPLASMS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84951757609     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.11.021     Document Type: Article

References (55)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J. Clin 2010, 60:277-300. 10.3322/caac.20073.
2. Lim M.C., Moon E.K., Shin A., Jung K.W., Won Y.J., Seo S.S., et al. Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010. J. Gynecol. Oncol 2013, 24:298-302. 10.3802/jgo.2013.24.4.298.
3. Goff B.A., Mandel L., Muntz H.G., Melancon C.H. Ovarian carcinoma diagnosis. Cancer 2000, 89:2068-2075.
4. Eisenkop S.M., Friedman R.L., Wang H.J. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol. Oncol 1998, 69:103-108. 10.1006/gyno.1998.4955.
5. Yap T.A., Carden C.P., Kaye S.B. Beyond chemotherapy: targeted therapies in ovarian cancer. Nat. Rev. Cancer 2009, 9:167-181. 10.1038/nrc2583.
6. Banerjee S., Gore M. The future of targeted therapies in ovarian cancer. Oncologist 2009, 14:706-716. 10.1634/theoncologist.2009-0013.
7. Kipps E., Tan D.S., Kaye S.B. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat. Rev. Cancer 2013, 13:273-282. 10.1038/nrc3432.
8. Jung K.W., Park S., Kong H.J., Won Y.J., Lee J.Y., Seo H.G., et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 2012, 44:11-24. 10.4143/crt.2012.44.1.11.
9. Capiod T. Cell proliferation, calcium influx and calcium channels. Biochimie 2011, 93:2075-2079. 10.1016/j.biochi.2011.07.015.
10. Rizzuto R., Pinton P., Ferrari D., Chami M., Szabadkai G., Magalhaes P.J., et al. Calcium and apoptosis: facts and hypotheses. Oncogene 2003, 22:8619-8627. 10.1038/sj.onc.1207105.
11. Periasamy M., Kalyanasundaram A. SERCA pump isoforms: their role in calcium transport and disease. Muscle Nerve 2007, 35:430-442. 10.1002/mus.20745.
12. Rosado J.A., Redondo P.C., Pariente J.A., Salido G.M. Calcium signalling and tumorigenesis. Cancer Ther 2004, 2:263-270.
13. Papp B., Brouland J., Arbabian A., Gélébart P. Endoplasmic reticulum calcium pumps and cancer cell differentiation. Biomolecules 2012, 2:165-186.
14. 2+ transport. Nat. Rev. Cancer 2007, 7:519-530. 10.1038/nrc2171.
15. 2+-ATPase 2 by curcumin induces ER stress-associated apoptosis for treating human liposarcoma. Mol. Cancer Ther 2011, 10:461-471. 10.1158/1535-7163.MCT-10-0812.
16. Bowen N.J., Walker L.D., Matyunina L.V., Logani S., Totten K.A., Benigno B.B., et al. Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC Med. Genomics 2009, 2:71. 10.1186/1755-8794-2-71.
17. Chen H., Lee J., Huang J., Wang C. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res 2008, 68:7428-7438.
18. Mehta K., Pantazis P., McQueen T., Aggarwal B.B. Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 1997, 8:470-481.
19. Kawamori T., Lubet R., Steele V.E., Kelloff G.J., Kaskey R.B., Rao C.V., et al. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 1999, 59:597-601.
20. Deeb D., Jiang H., Gao X., Hafner M.S., Wong H., Divine G., et al. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Mol. Cancer Ther 2004, 3:803-812.
21. Watson J.L., Greenshields A., Hill R., Hilchie A., Lee P.W., Giacomantonio C.A., et al. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and akt signaling. Mol. Carcinog 2010, 49:13-24. 10.1002/mc.20571.
22. Weir N.M., Selvendiran K., Kutala V.K., Tong L., Vishwanath S., Rajaram M., et al. Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol. Ther 2007, 6:178-184. 10.4161/cbt.6.2.3577.
23. Shi M., Cai Q., Yao L., Mao Y., Ming Y., Ouyang G. Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol. Int 2006, 30:221-226. 10.1016/j.cellbi.2005.10.024.
24. 2+ pumps by curcumin. Curcumin putatively stabilizes the interaction between the nucleotide-binding and phosphorylation domains in the absence of ATP. Eur. J. Biochem 2001, 268:6318-6327. http://dx.doi.org/10.1046/j.0014-2956.2001.02589.x.
25. 2+-ATPase of sarcoplasmic reticulum from paired inhibitor studies. Biochemistry 2002, 41:2869-2875. 10.1021/bi011938n.
26. Bozidis P., Williamson C.D., Colberg-Poley A.M. Isolation of endoplasmic reticulum, mitochondria, and mitochondria-associated membrane fractions from transfected cells and from human cytomegalovirus-infected primary fibroblasts. Curr. Protoc. Cell Biol 2007, Chapter 3:Unit 3.27.
27. Li Y., Ge M., Ciani L., Kuriakose G. Enrichment of endoplasmic reticulum with cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2b activity in parallel with increased order of membrane lipids: implications for depletion of endoplasmic reticulum calcium stores and apoptosis in cholesterol-loaded macrophages. J. Biol. Chem 2004, 279:37030-37039.
28. Schnekenburger M., Grandjenette C., Ghelfi J., Karius T., Foliguet B., Dicato M., et al. Sustained exposure to the DNA demethylating agent, 2'-deoxy-5- azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence, and autophagy. Biochem. Pharmacol 2011, 81:364-378. 10.1016/j.bcp.2010.10.013.
29. Syng-Ai C., Kumari A.L., Khar A. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol. Cancer Ther 2004, 3:1101-1108.
30. Maier E., Kurz K., Jenny M., Schennach H., Ueberall F., Fuchs D. Food preservatives sodium benzoate and propionic acid and colorant curcumin suppress Th1-type immune response in vitro. Food Chem. Toxicol 2010, 48:1950-1956. 10.1016/j.fct.2010.04.042.
31. Vyas H.K., Pal R., Vishwakarma R., Lohiya N.K., Talwar G.P. Selective killing of leukemia and lymphoma cells ectopically expressing hCGbeta by a conjugate of curcumin with an antibody against hCGbeta subunit. Oncology 2009, 76:101-111. 10.1159/000188665.
32. Kunwar A., Barik A., Mishra B., Rathinasamy K., Pandey R., Priyadarsini K.I. Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells. Biochim. Biophys. Acta 2008, 1780:673-679. 10.1016/j.bbagen.2007.11.016.
33. Singer S. The molecular organization of membranes. Annu. Rev. Biochem 1974, 1:199-208.
34. Singer S.J. Some early history of membrane molecular biology. Annu. Rev. Physiol 2004, 66:1-27. 10.1146/annurev.physiol.66.032902.131835.
35. Hsu C.-H., Cheng A.-L. Clinical studies with curcumin. Adv. Exp. Med. Biol 2007, 595:471-480. 10.1007/978-0-387-46401-5_21.
36. Bell D., Berchuck A., Birrer M., Chien J., Cramer D.W., Dao F., et al. Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474:609-615. 10.1038/nature10166.
37. Wu R., Baker S.J., Hu T.C., Norman K.M., Fearon E.R., Cho K.R. Type I to type II ovarian carcinoma progression: mutant Trp53 or Pik3ca confers a more aggressive tumor phenotype in a mouse model of ovarian cancer. Am. J. Pathol 2013, 182:1391-1399. 10.1016/j.ajpath.2012.12.031.
38. Szabova L., Yin C., Bupp S., Guerin T.M., Schlomer J.J., Householder D.B., et al. Perturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer. Cancer Res 2012, 72:4141-4153. 10.1158/0008-5472.CAN-11-3834.
39. Yang X., Fraser M., Moll U.M., Basak A., Tsang B.K. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway. Cancer Res 2006, 66:3126-3136. 10.1158/0008-5472.CAN-05-0425.
40. Watson J.L., Hill R., Yaffe P.B., Greenshields A., Walsh M., Lee P.W., et al. Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells. Cancer Lett 2010, 297:1-8. 10.1016/j.canlet.2010.04.018.
41. Bush J.A., Cheung K.J., Li G. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp. Cell Res 2001, 271:305-314. 10.1006/excr.2001.5381.
42. Innamaa A., Jackson L., Asher V., Van Schalkwyk G., Warren A., Keightley A., et al. Expression and effects of modulation of the K2P potassium channels TREK-1 (KCNK2) and TREK-2 (KCNK10) in the normal human ovary and epithelial ovarian cancer. Clin. Transl. Oncol 2013, 15:910-918. 10.1007/s12094-013-1022-4.
43. Yallapu M.M., Maher D.M., Sundram V., Bell M.C., Jaggi M., Chauhan S.C. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J. Ovarian Res 2010, 3:11. 10.1186/1757-2215-3-11.
44. Bava S.V., Puliappadamba V.T., Deepti A., Nair A., Karunagaran D., Anto R.J. Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-κB and the serine/threonine kinase Akt and is independent of tubulin polymerization. J. Biol. Chem 2005, 280:6301-6308.
45. Reuter S., Eifes S., Dicato M. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem. Pharmacol 2008, 76:1340-1351.
46. Hobson S.A., McNeil S.E., Lee F., Rodland K.D. Signal transduction mechanisms linking increased extracellular calcium to proliferation in ovarian surface epithelial cells. Exp. Cell Res 2000, 258:1-11. 10.1006/excr.2000.4910.
47. Xu Y., Gaudette D.C., Boynton J.D., Frankel A., Fang X.J., Sharma A., et al. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin. Cancer Res 1995, 1:1223-1232.
48. 2+ in toxic cell killing. Trends Pharmacol. Sci 1989, 10:281-285. 10.1016/0165-6147(89)90029-1.
49. Orrenius S., Zhivotovsky B., Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol 2003, 4:552-565. 10.1038/nrm1150.
50. Lin S.S., Huang H.P., Yang J.S., Wu J.Y., Hsai T.C., Lin C.C., et al. DNA damage and endoplasmic reticulum stress mediated curcumin-induced cell cycle arrest and apoptosis in human lung carcinoma A-549 cells through the activation caspases cascade- and mitochondrial-dependent pathway. Cancer Lett 2008, 272:77-90. 10.1016/j.canlet.2008.06.031.
51. 2+ and the activation of caspase-3. Anticancer Res 2006, 26:4379-4389.
52. Mattson M.P., Chan S.L. Calcium orchestrates apoptosis. Nat. Cell Biol 2003, 5:1041-1043. 10.1038/ncb1203-1041.
53. Lipskaia L., Hulot J.S., Lompre A.M. Role of sarco/endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation. Pflugers Arch 2009, 457:673-685. 10.1007/s00424-007-0428-7.
54. Chung F.-Y., Lin S.-R., Lu C.-Y., Yeh C.-S., Chen F.-M., Hsieh J.-S., et al. Sarco/endoplasmic reticulum calcium-ATPase 2 expression as a tumor marker in colorectal cancer. Am. J. Surg. Pathol 2006, 30:969-974. 10.1097/00000478-200608000-00006.
55. Li M., Balch C., Montgomery J.S., Jeong M., Chung J.H., Yan P., et al. Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer. BMC Med. Genomics 2009, 2:34. 10.1186/1755-8794-2-34.